While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific geographic regions. Therefore, in addition to our disease-specific repurposing communities, we work to increase the repurposing research focused on improving the quality and length of life within the Chicagoland region through the speed and cost-effectiveness of medical repurposing.
Our events and research within the the Chicagoland Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.
Repurposing for Pediatric Patients: Best Practices and Lessons Learned
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.
How Patients Impact the 505(b)(2) Regulatory Process
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.
CureAccelerator Live for Chicago 2020
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials.
CureAccelerator Live! for Rare Diseases 2020
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients.
Cutting Edge Treatments and Technologies for Diabetes Patients
A patient education event on groundbreaking treatments, technologies and strategies for diabetes patients to manage their disease, reduce co-morbidities and improve quality of life.
2018 Global Health Repurposing Awards
Recognizing leaders from industry, research and philanthropic who have created patient impact through the repurposing in oncology.
2017 Global Health Repurposing Awards
Recognizing leaders from industry, research and philanthropic who have created patient impact through repurposing in rare diseases.
CureAccelerator Live! for Oncology 2017
Five finalists from institutions across the US competing for up to $50,000 to fund their oncology repurposing clinical trials.
CureAccelerator Live! for Chicago 2016
Three finalists from Chicago-area institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials.